0001209191-18-037359.txt : 20180613
0001209191-18-037359.hdr.sgml : 20180613
20180613080014
ACCESSION NUMBER: 0001209191-18-037359
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180612
FILED AS OF DATE: 20180613
DATE AS OF CHANGE: 20180613
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: LAWRENCE DAVID
CENTRAL INDEX KEY: 0001272353
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-31938
FILM NUMBER: 18895888
MAIL ADDRESS:
STREET 1: C/O ACORDA THERAPEUTICS, INC.
STREET 2: 420 SAW MILL RIVER ROAD
CITY: ARDSLEY
STATE: NY
ZIP: 10502
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ACORDA THERAPEUTICS INC
CENTRAL INDEX KEY: 0001008848
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 000000000
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 420 SAW MILL RIVER ROAD
CITY: ARDSLEY
STATE: NY
ZIP: 10502
BUSINESS PHONE: 914-347-4300
MAIL ADDRESS:
STREET 1: 420 SAW MILL RIVER ROAD
CITY: ARDSLEY
STATE: NY
ZIP: 10502
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-06-12
0
0001008848
ACORDA THERAPEUTICS INC
ACOR
0001272353
LAWRENCE DAVID
420 SAW MILL RIVER ROAD
ARDSLEY
NY
10502
0
1
0
0
Chief, Bus. Ops & PAO
Common Stock
2018-06-12
4
S
0
3131
31.651
D
4993
D
Common Stock
2018-06-12
4
S
0
300
32.6833
D
4693
D
Sales pursuant to a 10b5-1 plan.
The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $31.40 to $32.10 per share. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $32.60 to $32.80 per share. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
/s/ David Lawrence
2018-06-13